Loading the company…
Loading the company…
Families: Hysterectomy, hysteroscopy & ablation, Kidney stone management.
All companies · Product and company coverage
In the last ten years FDA made 2 decisions for Zhejiang Geyi Medical Instrument (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2026 (1). The latest was on 2026-09-08.
| Family | Decisions on record |
|---|---|
| Hysterectomy, hysteroscopy & ablation | 1 |
| Kidney stone management | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-09-08 | 510(k) | K254294 | Single-use Digital Hysteroscope (GYUT-A 12.6- 0, GYUT-A12.6- 12, GYUT-A 12.6- 22, GYUT-A 12.6- 30, GYUT-A 14.4- 0, GYUT-A 14.4- 12,GYUT-A 14.4- 22, GYUT-A 14.4- 30, GYUT-B 15- 0, GYUT-B 15- 12, GYUT-B 15-22, GYUT-B 15- 30) |
| 2025-12-16 | 510(k) | K252468 | Single-use Digital Flexible Ureteroscope (GY-UR9.3); Single-use Digital Flexible Ureteroscope (GY-UR8.4); Single-use Digital Flexible Ureteroscope (GY-UR7.5); Endoscope camera system (GY-AIO-121) |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Zhejiang Geyi Medical Instrument.